Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
I write in response to the article published in your journal “Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia” (Bruno C et al, BMJ Qual Saf 2019). I am writing as NPS MedicineWise evaluation found a significant impact on general practitioner (GP) prescribing of proton pump inhibitors (PPIs) following their educational programmes in 2009 and 2015. I acknowledge that the article is well written, the methods are well described and the approach includes a number of sensitivity analyses. However, I would like to highlight some key points on the analysis methods used that differ from the approach taken by NPS MedicineWise and about which I have some concerns.
The 2015 NPS MedicineWise educational programme on PPIs was part of a larger educational strategy over a decade to support best-practice prescribing of PPIs by GPs and included Pharmaceutical Benefits Scheme (PBS) feedback to GPs in Australia. This consists of a letter that includes information of the individual GP’s prescribing of PPIs compared with …
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; internally peer reviewed.